Your trusted source for investing success
The biotech sector has steadily enjoyed an increase this year, in part thanks to significant advancements and in spite of the uncertainty from the White House as the proposal of a new healthcare bill holds the grip of most life science markets.
CASI Pharmaceuticals, Savara, Adverum Biotechnologies, ChromaDex Therapeutics and MannKind top the NASDAQ biotech stock list.
In the cleanest form Biotechnology refers to the sector that through cellular and biomolecular methods to improve or create products in various industries.
Neovasc, Adaptimmune, Curis, Vericel and MannKind top the NASDAQ biotech stock list.
Delcath Systems, MannKind, Zogenix, BioLife Solutions and BioDelivery Sciences top the NASDAQ biotech stock list.
Pharmaceutical companies work towards achieving the goal of bringing new cures or treatments to the market and improve the treatment available for patients.
By Jocelyn Aspa
The US Department of Energy’s report shows that wind energy prices are at significant lows compared to 2009.
Reports have indicated to the growth for the industry based on the curiosity and need for patients to find new therapies involved to their diseases.
Cogentix Medical, Molecular Templates, Celldex Therapeutics, Cerus and Kura Oncology top the NASDAQ biotech stock list.
Here, the Investing News Network provides a breakdown of how to invest in cardiovascular disease treatments and what the market outlook looks like.
Novavax, Agenus, Sierra Oncology, Durect and Cogentix top the NASDAQ biotech stock list.
Biotechnology has fully cemented itself as a distinct side of the life science market, often offering companies the availability to work in pharmaceutical more general health products.
Data from the P&S Market Research indicated the already lucrative global animal pharmaceutical market, valued at $12,614.3 million total in 2015, will increase at a CAGAR of 7.7 percent by 2022.
With recreational use of cannabis set to be fully legalized in Canada next year, speculation is circulating as to whether or not there will be enough market supply.
MEI Pharma, AVEO Pharmaceuticals, Albireo Pharma, Athersys and CASI Pharmaceuticals top the list.
A new preliminary research report from the Canadians for Fair Access to Medical Marijuana group shows that under current laws, medical cannabis users could face impaired driving charges through a method which doesn’t accurately test them.
As investors look ahead at the remainder of 2017, the INN put together a list of the top gaining pharmaceutical stocks on the Toronto Stock Exchange.
By Jocelyn Aspa
Data stocks on the TSX are performing well so far in 2017. Here’s a look at the 5 top performing data stocks at the halfway mark of the year.
By Melissa Shaw
Wondering how to invest in the vanadium industry? Learn about supply and demand, as well as firms involved in the vanadium space.
The Investing News Network had the chance to speak with Titan Medical CEO about its robotic medical application and how the company looks to compete in the robotics surgery market.
